Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma Lena Håkansson,

Slides:

Advertisements

Similar presentations

Assessment of inflammation in noninfectious chronic maxillary sinusitis Pascal Demoly, MDa, Louis Crampette, MDb, Michel Mondain, MDb, Alison M. Campbell,

Advertisements

Daniela P. Metz, PhDa, Annette S

Shin-Ichi Nishikawa, MD, PhD

Expression of FcγRIII (CD16) on human peripheral blood eosinophils increases in allergic conditions Francis Davoine, MSc, Sophie Lavigne, MSc, Jamila.

Pharmacologic rationale for treating allergic and nonallergic rhinitis

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.

Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma Makoto Hoshino, MDa, Yutaka Nakamura, MDa,

Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,

Ann-Marie M. Schoos, MD, PhD, Jacob D

The role of viruses in acute exacerbations of asthma

The Editors' Choice Journal of Allergy and Clinical Immunology

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug- induced cutaneous eruptions Nikhil Yawalkar, MD, Maithili Shrikhande,

Microvascular responses to sepsis: clinical significance

Is 9 more than 2 also in allergic airway inflammation?

Practice Notes from the AAAI

Deposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the.

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis Carmen Rondón, MD, PhD, Paloma Campo,

Elephantiasis nostras: A case report

Jerome A. Sigua, MD, Becky Buelow, MD, Dorothy S

The impact of allergic rhinitis on bronchial asthma

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity

Expression of activated FcγRII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects Deon.

Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways Anthony J. Frew, MD, Johanne St-Pierre,

Practice Notes from the AAAAI

Obstructive sleep apnea

A review of the current guidelines for allergic rhinitis and asthma

Evidence for expression of eosinophil-associated IL-12 messenger RNA and immunoreactivity in bronchial asthma Esra Nutku, MDa, Abdelilah Soussi Gounni,

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Pathophysiology of the inflammatory response

News & Notes Journal of Allergy and Clinical Immunology

Basophils and eosinophils in allergic rhinitis

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Daniela P. Metz, PhDa, Annette S

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.

CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

What is an “eosinophilic phenotype” of asthma?

Vascular endothelial growth factor in patients with acute asthma

Autophagy: Nobel Prize 2016 and allergy and asthma research

News & Notes Journal of Allergy and Clinical Immunology

Assessment of inflammation in noninfectious chronic maxillary sinusitis Pascal Demoly, MDa, Louis Crampette, MDb, Michel Mondain, MDb, Alison M. Campbell,

Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells Sun Ying, MD, PhD,

A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.

Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma Yutaro Shiota, MD, PhDa, Hitomi Arikita, MTa, Naokatsu Horita, MDb,

Chemokines and their receptors in allergic disease

Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation Hiroshi Tachimoto, MD, PhD, Sherry A. Hudson, MSB, Bruce.

Loratadine reduces allergen-induced mucosal output of α2-macroglobulin and tryptase in allergic rhinitis Lennart Greiff, MD, PhDa, Carl G.A. Persson,

Peter J. Barnes, DM, DSc, FRCP

Thomas E. Van Metre, MD, Gary L. Rosenberg, MD, Surender K

Seasonal rhinitis and azelastine: Long- or short-term treatment

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis François Lavigne, MDa, Cong Thu Nguyen, MDa, Lisa Cameron,

Practice Notes from the AAAI

Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways Gert-Jan Braunstahl, MDa, b, Shelley.

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Footnotes1 Journal of Allergy and Clinical Immunology

Prescott G. Woodruff, MD, MPH, Ramin Khashayar, MD, Stephen C

IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy Kayhan T. Nouri-Aria, PhD, FRCPath, Charles.

Evelyn Farinas, RPh, MGA, Peter Honig, MD

Systemic effects of local allergic disease

The environmental predictors of allergic disease

Tuomas Jartti, MD, James E. Gern, MD

Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4,

News & Notes Journal of Allergy and Clinical Immunology

Advances in mechanisms of allergic disease in 2016

Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis Christine Riedhammer,

Presentation transcript:

Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma Lena Håkansson, PhDa,c, Eythor Björnsson, MD, PhDb,c, Christer Janson, MD, PhDb,c, Birgitta Schmekel, MD, PhDc,d Journal of Allergy and Clinical Immunology Volume 96, Issue 6, Pages 941-950 (December 1995) DOI: 10.1016/S0091-6749(95)70232-6 Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Adhesion of eosinophil (A) and neutrophil (B) granulocytes from healthy individuals (n = 9), patients with allergic rhinitis (n = 10), patients with allergic asthma (n = 10), and patients with nonallergic asthma (n = 10) to E-selectin, VCAM-1, and ICAM-1. Results shown are median values and upper quartiles. Zero level represents background adhesion to native BHK fibroblasts. Journal of Allergy and Clinical Immunology 1995 96, 941-950DOI: (10.1016/S0091-6749(95)70232-6) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 2 Adhesion of eosinophil (A) and neutrophil (B) granulocytes from healthy individuals (n = 9), patients with PEF variability of less than 10% (n = 12), and patients with PEF variability of more than 10% (n = 9) to E-selectin, VCAM-1, and ICAM-1. Results shown are median values and upper quartiles. Significances of difference among results of patients with >10% PEF variability, healthy individuals, and patients with <10% PEF variability, calculated by means of the Mann-Whitney U test, are indicated. Journal of Allergy and Clinical Immunology 1995 96, 941-950DOI: (10.1016/S0091-6749(95)70232-6) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 3 Specific eosinophil (A) and neutrophil (B) cell surface expression of CD11b, CD18, and CD49d in healthy individuals (n = 9), patients with PEF variability of less than 10% (n = 12), and patients with PEF variability of more than 10% (n = 9). Results shown are median values and upper quartiles. Zero level represents background fluorescence (mean, 1.1 U; range, 1.0 to 1.66 U). Neutrophils do not express CD49d (mean, 0.0; range, 0.0 to 0.005). Journal of Allergy and Clinical Immunology 1995 96, 941-950DOI: (10.1016/S0091-6749(95)70232-6) Copyright © 1995 Mosby, Inc. Terms and Conditions